Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
|  | 
Georgia CTSA
Weekly eRoundup
May 18, 2018
|
| |
| | | | | Vani Manoharan, RN, is an Emory Healthcare nurse clinician for the Georgia Clinical & Translational Science Alliance's (Georgia CTSA) Georgia CTSA Clinical Research Centers (GCRC) site at Emory University Hospital. She received the award Nurse of the Year 2018 from the Georgia Indian Nurses Association (GINA) based on excellence in professional practice.
Manoharan has worked in Emory Healthcare’s Inpatient Clinical Research Unit since ... | | | | Read More | | |
|
| |
| | | | | Xingyu Zhang, PhD, postdoc fellow, Department of Surgery, Emory School of Medicine, received first place for "Use of clinical notes on electronic medical record data to improve prediction of 30-day hospital readmission after kidney transplantation." Dian Dowling Evans, PhD, professor, Emory School of Nursing, received second place for "The emergency department as setting for female pelvic examination” Thank you to all those who partici ... | | | | Read More | | |
|
| |
| | | | The foundation supports research in two areas medical research and science and engineering. The Foundation seeks research that applies a distinctive and novel approach that questions a prevailing paradigm or offers the potential to open new territory in the field. | | | | Read More | | |
| |
| | | | The Bill and Melinda Gates Foundation seeks proposals that engage scientists across a variety of disciplines, including those new to the influenza field, demonstrate innovative thinking by incorporating concepts or technologies not currently being used within/addressed by the influenza vaccine field, present concepts and strategies that are off the beaten track, significantly radical in conception, and daring in premise. | | | | Read More | | |
| |
| | | | This Pathway to Stop Diabetes initiative accepts nominations for exceptional investigators with medical and scientific backgrounds who propose innovative basic, clinical, translational, behavioral, epidemiological and health services research relevant to any type of diabetes, diabetes-related disease state or complication. | | | | Read More | | |
| |
| | | | The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support and increased flexibility to Program Directors/Principal Investigators whose records of research achievement demonstrate their ability to make major contributions to neuroscience. | | | | Read More | | |
| |
| | | | The purpose of this FOA is to provide support for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the National Heart, Lung, and Blood Institute (NHLBI) and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation. | | | | Read More | | |
| |
| | | | The goal of the Informatics Research Starter Grants program is to promote development and use of novel informatics in an integrative approach toward understanding normal processes of human biology and disease processes. The awards offer financial support to individuals beginning independent research careers in pharmaceutics (including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, and pharmaceutical biotechnology) at the faculty level. | | | | Read More | | |
| |
| | | | This FOA invites applications for studies to understand the effects of type 1 diabetes (T1D) on bone mass and quality and/or fracture risk. Researchers may propose investigations in newly recruited subjects or using subjects and/or samples from ongoing clinical studies of individuals with for T1D. | | | | Read More | | |
| |
| | | | To give research teams extra time to consider their applications, PCORI posted five research funding preannouncements. Two preannouncements describe soon-to-be-reopened funding opportunities; one focuses on medication-assisted treatment delivery for pregnant women with substance use disorders and the other focuses on symptom management for advanced illnesses. A third preannouncement focuses on addressing health disparities and a fourth on improving methods for conducting patient-centered outcomes research. The fifth preannouncement will focus on the implementation of effective shared decision making approaches in healthcare settings. | | | | Read More | | |
| |
| | | | The institute will utilize a combination of a 4-month online course (six modules with related assignments) between August 13 and November 30, and a two-day in-person training to be held December 6-7, in Bethesda, MD. Faculty and guest lecturers will consist of leading experts in theory, implementation, and evaluation approaches to D&I; creating partnerships and multilevel, transdisciplinary research teams; research design, methods, and analyses appropriate for D&I; and conducting research at different and multiple levels of intervention (e.g., clinical, community, policy). | | | | Read More | | |
| |
| | | | The program seeks to stimulate fundamental research by early-career scientists and scholars of outstanding promise. Successful candidates generally have a strong record of significant independent research accomplishments that demonstrate creativity and the potential to become future leaders in the scientific community. Fellowships are awarded in the following categories Chemistry, Computational & Evolutionary Molecular Biology, Computer Science, Economics, Mathematics, Neuroscience, Ocean Sciences, and Physics. | | | | Read More | | |
| |
| | | | The objective of the award is to support young gastroenterologists working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for research. | | | | Read More | | |
| |
| | | | Featured speakers include Jane McCracken, Interim General Manager, ATDC; Russell M. Medford MD, PhD, Managing Partner, The Salutramed Group, Inc.; and Cliff Michaels, Assistant Director, Licensing Group, Emory University Office of Technology Transfer. Qualified applicants who have attended four out of five sessions will receive automatic placement on the 2018 Innovation Stage at the Georgia Bio Innovation Summit. This stage was highly competitive last year. | | | | Read More | | |
| |
| | | | | A team of MBAs and JDs can help you commercialize your research! Learn more about TI:GER (Tech Innovation: Generating Economic Results), a program within Georgia Tech's Scheller College of Business.
Learn more about the program ... | | | | Read More | | |
|
| |
| | | | The Health Resources and Services Administration's Federal Office of Rural Health Policy plans to award up to 75 grants to rural communities as part of a new Rural Communities Opioid Response Planning initiative in FY 18. Successful awardees will receive up to $200,000 for one-year to develop plans to implement opioid use disorder prevention, treatment, and recovery interventions designed to reduce opioid overdoses among rural populations. | | | | Read More | | |
| |
| | | | The American Heart Association and the Robert Wood Johnson Foundation are working to create a culture of health with the Voices for Healthy Kids initiative. Through this collaboration, and in partnership with a team of experts across the healthy eating and active living movement, the initiative aims to engage, organize, and mobilize people to help all children grow up at a healthy weight. | | | | Read More | | |
| |
| | | | Free seminar at 12:00 p.m. in Emory's Rollins School of Public Health's Claudia Nance Rollins Building, Room 3001 | | | | Read More | | |
| |
| | | | The Georgia Bio Emerging Leaders Network and the Atlanta BEST Program have organized a series of networking and panel events focused on raising awareness of career paths that exist in life sciences for individuals with advanced degrees. This session will highlight economic development and government affairs. | | | | Read More | | |
| |
| | | | This conference will explore the inherent limitations of using group data to guide treatment decisions for individuals. This conference will take a broad view of personalized/precision medicine that seeks to take into account the full gamut of patient-level variation. Conference participants will include thought leaders and stakeholders who are developing and promulgating methods for more individualized evidence from academic, government, and regulatory sectors. | | | | Read More | | |
| |
| | | | | Join researchers from across the Georgia CTSA as Emory and Morehouse researchers share information on interests, research, and resources in extracellular vesicles (EVs). Blue Sky Groups are convened to discuss common research areas and identify potential areas of collaboration. These groups meet once to discuss a broad topic, and then future meetings are organized based on interests and potential outcomes. ... | | | | Read More | | |
|
| |
| | | | Presented by VA Informatics and Computing Infrastructure. The intended audience is new and existing users of OMOP data. | | | | Read More | | |
| |
| | | | | | ResearchMatch.org is our national web platform that brings together people that are interested in participating in research with the research community. The speaker will discuss how ResearchMatch matches potential volunteers with clinical and survey studies and how to use filters and pre-screening surveys to refine recruitment efforts. | | | | Read More | | |
|
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|
